Trial intelligence / Profile preview

Oliceridine vs Fentanyl with Propofol for Respiratory Depression During Gastrointestinal Endoscopy

ChiCTR2500096869Phase 4Not yet recruiting

Sponsor
Changshu No.2 People's Hospital
Start
Feb 2025
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in procedural pain and procedural sedation and analgesia (PSA) comparing Oliceridine + propofol with Fentanyl + propofol (2 arms). Primary endpoint: Incidence of SpO2 < 95% or respiratory rate < 10 breaths/min. Planned start Feb 2025; status: not yet recruiting.

02

Drugs

oliceridinefentanylpropofol
03

Conditions

procedural painprocedural sedation and analgesia (PSA)

Beyond the preview

Go deeper on ChiCTR2500096869.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500096869.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call